Cargando…

Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle

The ATP-sensitive K(+) (KATP) channel is an emerging pathway in the skeletal muscle atrophy which is a comorbidity condition in diabetes. The “in vitro” effects of the sulfonylureas and glinides were evaluated on the protein content/muscle weight, fibers viability, mitochondrial succinic dehydrogena...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mele, Antonietta, Calzolaro, Sara, Cannone, Gianluigi, Cetrone, Michela, Conte, Diana, Tricarico, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186404/ https://www.ncbi.nlm.nih.gov/pubmed/25505577 http://dx.doi.org/10.1002/prp2.28

Ejemplares similares

Emerging Role of Calcium-Activated Potassium Channel in the Regulation of Cell Viability Following Potassium Ions Challenge in HEK293 Cells and Pharmacological Modulation
por: Tricarico, Domenico, et al.
Publicado: (2013)

Glinide, but Not Sulfonylurea, Can Evoke Insulin Exocytosis by Repetitive Stimulation: Imaging Analysis of Insulin Exocytosis by Secretagogue-Induced Repetitive Stimulations
por: Aoyagi, Kyota, et al.
Publicado: (2009)

In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography
por: Mele, Antonietta, et al.
Publicado: (2016)

Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes switched from glinides
por: Tanaka, Tsuyoshi, et al.
Publicado: (2013)

Splicing of the rSlo Gene Affects the Molecular Composition and Drug Response of Ca(2+)-Activated K(+) Channels in Skeletal Muscle
por: Dinardo, Maria Maddalena, et al.
Publicado: (2012)

Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options
por: Camerino, Giulia Maria, et al.
Publicado: (2019)

Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity
por: Camerino, Giulia Maria, et al.
Publicado: (2013)

Commentary: A BK (Slo1) channel journey from molecule to physiology
por: Tricarico, Domenico, et al.
Publicado: (2017)

Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome
por: Scala, Rosa, et al.
Publicado: (2020)

Molecular modeling of antibodies for the treatment of TNF α‐related immunological diseases
por: Pierri, Ciro Leonardo, et al.
Publicado: (2016)

Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Osteocalcin Gene Relationship in Energy Regulation, Bone Homeostasis and Reproductive Organs Analyzed by mRNA Quantitative Evaluation and Linear Correlation Analysis
por: Camerino, Claudia, et al.
Publicado: (2016)

Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome
por: Scala, Rosa, et al.
Publicado: (2021)

Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury
por: Otzel, Dana M., et al.
Publicado: (2021)

The large conductance Ca(2+) -activated K(+) (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases
por: Curci, Angela, et al.
Publicado: (2014)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin‐induced cachexia
por: Conte, Elena, et al.
Publicado: (2017)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

Impact of short-term, pharmacological CARM1 inhibition on skeletal muscle mass, function, and atrophy in mice
por: Webb, Erin K., et al.
Publicado: (2023)

ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force
por: Tricarico, Domenico, et al.
Publicado: (2016)

Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)

Sulfonylureas: Scoring beyond START STUDY
por: Shaikh, Altamash
Publicado: (2017)

Sulfonylurea and neuroprotection: The bright side of the moon
por: Hussien, Nawar R., et al.
Publicado: (2018)

The Place of Sulfonylureas in Guidelines: Why Are There Differences?
por: Amod, Aslam
Publicado: (2020)

Latest Evidence on Sulfonylureas: What’s New?
por: Leiter, Lawrence A.
Publicado: (2020)

Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Recent Advances in the Pathogenesis and Drug Action in Periodic Paralyses and Related Channelopathies
por: Tricarico, Domenico, et al.
Publicado: (2011)

Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database
por: Tanabe, Makito, et al.
Publicado: (2015)

Inflammation: Roles in Skeletal Muscle Atrophy
por: Ji, Yanan, et al.
Publicado: (2022)

Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation
por: Camerino, Giulia Maria, et al.
Publicado: (2015)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
por: Hwang, You-Cheol
Publicado: (2015)

Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis
por: Braet, Corey, et al.
Publicado: (2020)

The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy
por: Yu, Miao
Publicado: (2020)

The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy
por: Saberi, Meisam, et al.
Publicado: (2020)

Major channels involved in neuropsychiatric disorders and therapeutic perspectives
por: Imbrici, Paola, et al.
Publicado: (2013)

Potential Therapeutic Strategies for Skeletal Muscle Atrophy
por: Huang, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_saaa08rvck0kpcopst83gc3kt8